These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 24121962)
21. Entorhinal cortex of aged subjects with Down's syndrome shows severe neuronal loss caused by neurofibrillary pathology. Sadowski M; Wisniewski HM; Tarnawski M; Kozlowski PB; Lach B; Wegiel J Acta Neuropathol; 1999 Feb; 97(2):156-64. PubMed ID: 9928826 [TBL] [Abstract][Full Text] [Related]
22. The relationship between the morphological subtypes of microglia and Alzheimer's disease neuropathology. Paasila PJ; Davies DS; Kril JJ; Goldsbury C; Sutherland GT Brain Pathol; 2019 Nov; 29(6):726-740. PubMed ID: 30803086 [TBL] [Abstract][Full Text] [Related]
23. Memory performance is related to amyloid and tau pathology in the hippocampus. Reitz C; Honig L; Vonsattel JP; Tang MX; Mayeux R J Neurol Neurosurg Psychiatry; 2009 Jul; 80(7):715-21. PubMed ID: 19258354 [TBL] [Abstract][Full Text] [Related]
24. Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia. Luterman JD; Haroutunian V; Yemul S; Ho L; Purohit D; Aisen PS; Mohs R; Pasinetti GM Arch Neurol; 2000 Aug; 57(8):1153-60. PubMed ID: 10927795 [TBL] [Abstract][Full Text] [Related]
25. Fibrillar amyloid-beta affects neurofibrillary changes but only in neurons already involved in neurofibrillary degeneration. Wegiel J; Bobinski M; Tarnawski M; Dziewiatkowski J; Popovitch E; Miller DC; Wisniewski T; Golomb J; de Leon MJ; Reisberg B Acta Neuropathol; 2001 Jun; 101(6):585-90. PubMed ID: 11515787 [TBL] [Abstract][Full Text] [Related]
26. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study. Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845 [TBL] [Abstract][Full Text] [Related]
27. Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer's disease. Pooler AM; Polydoro M; Maury EA; Nicholls SB; Reddy SM; Wegmann S; William C; Saqran L; Cagsal-Getkin O; Pitstick R; Beier DR; Carlson GA; Spires-Jones TL; Hyman BT Acta Neuropathol Commun; 2015 Mar; 3():14. PubMed ID: 25853174 [TBL] [Abstract][Full Text] [Related]
28. Lewy body variant of Alzheimer's disease or cerebral type lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem. Yokota O; Tsuchiya K; Uchihara T; Ujike H; Terada S; Takahashi M; Kimura Y; Ishizu H; Akiyama H; Kuroda S Neuropathology; 2007 Feb; 27(1):21-35. PubMed ID: 17319280 [TBL] [Abstract][Full Text] [Related]
29. Pathological changes in frontal cortex from biopsy to autopsy in Alzheimer's disease. Bennett DA; Cochran EJ; Saper CB; Leverenz JB; Gilley DW; Wilson RS Neurobiol Aging; 1993; 14(6):589-96. PubMed ID: 8295661 [TBL] [Abstract][Full Text] [Related]
31. Progression of neurofibrillary changes and PHF-tau in end-stage Alzheimer's disease is different from plaque and cortical microglial pathology. Thal DR; Arendt T; Waldmann G; Holzer M; Zedlick D; Rüb U; Schober R Neurobiol Aging; 1998; 19(6):517-25. PubMed ID: 10192210 [TBL] [Abstract][Full Text] [Related]
32. Orbitofrontal cortex pathology in Alzheimer's disease. Van Hoesen GW; Parvizi J; Chu CC Cereb Cortex; 2000 Mar; 10(3):243-51. PubMed ID: 10731219 [TBL] [Abstract][Full Text] [Related]
36. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease. Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982 [TBL] [Abstract][Full Text] [Related]
37. Cortical neuritic plaques and hippocampal neurofibrillary tangles are related to dementia severity in elderly schizophrenia patients. Rapp MA; Schnaider-Beeri M; Purohit DP; Reichenberg A; McGurk SR; Haroutunian V; Harvey PD Schizophr Res; 2010 Jan; 116(1):90-6. PubMed ID: 19896333 [TBL] [Abstract][Full Text] [Related]
38. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Arnold SE; Hyman BT; Flory J; Damasio AR; Van Hoesen GW Cereb Cortex; 1991; 1(1):103-16. PubMed ID: 1822725 [TBL] [Abstract][Full Text] [Related]
39. Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia. Janocko NJ; Brodersen KA; Soto-Ortolaza AI; Ross OA; Liesinger AM; Duara R; Graff-Radford NR; Dickson DW; Murray ME Acta Neuropathol; 2012 Nov; 124(5):681-92. PubMed ID: 22968369 [TBL] [Abstract][Full Text] [Related]
40. Regional distribution and maturation of tau pathology among phenotypic variants of Alzheimer's disease. Arezoumandan S; Xie SX; Cousins KAQ; Mechanic-Hamilton DJ; Peterson CS; Huang CY; Ohm DT; Ittyerah R; McMillan CT; Wolk DA; Yushkevich P; Trojanowski JQ; Lee EB; Grossman M; Phillips JS; Irwin DJ Acta Neuropathol; 2022 Dec; 144(6):1103-1116. PubMed ID: 35871112 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]